LUNG - Pulmonx Corporation
NASDAQ
->
Healthcare
->
Medical Devices
Redwood City,
United States
Type: Equity
LUNG price evolution
LUNG
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $54.13 | $63.72 | $70.39 | $83.78 |
| Short term investments | $51.08 | $45.97 | $33.55 | |
| Net receivables | $12.32 | $11.08 | $10.52 | $12.11 |
| Inventory | $16.96 | $19.28 | $19.75 | $19.32 |
| Total current assets | $140.93 | $146.16 | $147.94 | $150.42 |
| Long term investments | $4.29 | $14.39 | ||
| Property, plant & equipment | $21.22 | $21.32 | $6.92 | $7.43 |
| Goodwill & intangible assets | $2.33 | $2.33 | $2.36 | |
| Total noncurrent assets | $26.47 | $16.65 | $27.36 | |
| Total investments | $51.08 | $50.27 | $47.95 | |
| Total assets | $167.4 | $172.63 | $164.58 | $177.78 |
| Current liabilities | ||||
| Accounts payable | $4.58 | $3.18 | $3.13 | $1.5 |
| Deferred revenue | $0.11 | $0.11 | $0.1 | |
| Short long term debt | $1.16 | $7.92 | $5.23 | |
| Total current liabilities | $18.3 | $16.3 | $21.29 | $23.16 |
| Long term debt | $37.14 | $55.02 | $32.65 | $36.2 |
| Total noncurrent liabilities | $55.14 | $32.79 | $36.31 | |
| Total debt | $56.19 | $40.57 | $41.42 | |
| Total liabilities | $73.48 | $71.44 | $54.09 | $59.47 |
| Shareholders' equity | ||||
| Retained earnings | -$454.38 | -$440.24 | -$424.91 | -$411.16 |
| Other shareholder equity | $2.53 | $1.97 | $1.96 | $2.64 |
| Total shareholder equity | $101.18 | $110.5 | $118.31 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $83.78 | $97.09 | $148.71 | $231.79 |
| Short term investments | $33.55 | $39.4 | $31.56 | |
| Net receivables | $12.11 | $9.28 | $6.56 | $4.23 |
| Inventory | $19.32 | $14.56 | $16.29 | $10.74 |
| Total current assets | $150.42 | $168.95 | $208 | $249.99 |
| Long term investments | $14.39 | $5.92 | $10.94 | |
| Property, plant & equipment | $7.43 | $10.5 | $12.89 | $10.45 |
| Goodwill & intangible assets | $2.36 | $2.49 | $2.61 | $2.73 |
| Total noncurrent assets | $27.36 | $24.72 | $27.17 | $13.72 |
| Total investments | $47.95 | $45.33 | $42.5 | |
| Total assets | $177.78 | $193.68 | $235.17 | $263.71 |
| Current liabilities | ||||
| Accounts payable | $1.5 | $1.76 | $1.58 | $1.47 |
| Deferred revenue | $0.1 | $0.12 | $0.16 | $0.07 |
| Short long term debt | $5.23 | $3.32 | $2.29 | $2.24 |
| Total current liabilities | $23.16 | $18.49 | $17.55 | $12.53 |
| Long term debt | $36.2 | $17.23 | $24.17 | $24.99 |
| Total noncurrent liabilities | $36.31 | $21.18 | $24.38 | $25.05 |
| Total debt | $41.42 | $24.4 | $26.46 | $27.22 |
| Total liabilities | $59.47 | $39.67 | $41.93 | $37.57 |
| Shareholders' equity | ||||
| Retained earnings | -$411.16 | -$350.32 | -$291.39 | -$242.73 |
| Other shareholder equity | $2.64 | $1.57 | $1.71 | $1.69 |
| Total shareholder equity | $118.31 | $154.01 | $193.24 | $226.13 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $20.78 | $18.85 | $19.28 | |
| Cost of revenue | $5.48 | $4.78 | $4.88 | |
| Gross Profit | $15.31 | $14.08 | $14.4 | |
| Operating activities | ||||
| Research & development | $5.62 | $4.21 | $3.9 | |
| Selling, general & administrative | $25.31 | $24.4 | $24.42 | |
| Total operating expenses | $30.93 | $28.61 | $28.32 | |
| Operating income | -$15.62 | -$14.54 | -$13.92 | |
| Income from continuing operations | ||||
| EBIT | -$14.35 | -$12.68 | -$12.73 | |
| Income tax expense | $0.08 | $0.19 | $0.25 | |
| Interest expense | $0.89 | $0.88 | $0.91 | |
| Net income | ||||
| Net income | -$15.33 | -$13.75 | -$13.89 | |
| Income (for common shares) | -$15.33 | -$13.75 | -$13.89 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $68.67 | $53.66 | $48.42 | $32.73 |
| Cost of revenue | $17.92 | $13.8 | $12.79 | $11.53 |
| Gross Profit | $50.75 | $39.87 | $35.63 | $21.2 |
| Operating activities | ||||
| Research & development | $18.08 | $15.4 | $13.06 | $7.46 |
| Selling, general & administrative | $94.61 | $83.11 | $69.87 | $46.07 |
| Total operating expenses | $112.69 | $98.5 | $82.93 | $53.53 |
| Operating income | -$61.94 | -$58.64 | -$47.3 | -$32.33 |
| Income from continuing operations | ||||
| EBIT | -$57.04 | -$57.5 | -$47.49 | -$28.84 |
| Income tax expense | $0.57 | $0.35 | $0.34 | $0.21 |
| Interest expense | $3.23 | $1.07 | $0.83 | $3.18 |
| Net income | ||||
| Net income | -$60.84 | -$58.92 | -$48.66 | -$32.23 |
| Income (for common shares) | -$60.84 | -$58.92 | -$48.66 | -$32.23 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$15.33 | -$13.75 | -$13.89 | |
| Operating activities | ||||
| Depreciation | $0.91 | $1.12 | $0.98 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $5.92 | $5.67 | $5.6 | |
| Total cash flows from operations | -$5.77 | -$11.79 | -$8.45 | |
| Investing activities | ||||
| Capital expenditures | $0.45 | -$0.45 | -$0.2 | |
| Investments | -$0.37 | -$2.06 | -$2.56 | |
| Total cash flows from investing | $3.41 | -$0.83 | -$2.51 | -$2.75 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.02 | $0.86 | $0.06 | |
| Net borrowings | -$0.05 | -$0.05 | ||
| Total cash flows from financing | $1.3 | -$0.02 | $0.86 | $0.02 |
| Effect of exchange rate | -$0.12 | -$0.05 | $0.05 | -$0.21 |
| Change in cash and equivalents | -$20.21 | -$6.67 | -$13.39 | -$11.4 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$60.84 | -$58.92 | -$48.66 | -$32.23 |
| Operating activities | ||||
| Depreciation | $4.23 | $4.01 | $3.23 | $1.95 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $22.1 | $16.45 | $10.53 | $3.2 |
| Total cash flows from operations | -$37.61 | -$45.08 | -$41.39 | -$30.63 |
| Investing activities | ||||
| Capital expenditures | -$0.81 | -$1.32 | -$3.67 | -$0.91 |
| Investments | -$1.2 | -$2.91 | -$42.58 | $13.61 |
| Total cash flows from investing | -$2.01 | -$4.22 | -$46.26 | $12.69 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.49 | $2.56 | $4.5 | $204.08 |
| Net borrowings | $19.91 | -$0.14 | -$0.04 | $32.83 |
| Total cash flows from financing | $21.4 | $2.42 | $4.46 | $234.83 |
| Effect of exchange rate | $0.03 | $0.14 | $0.11 | $0.13 |
| Change in cash and equivalents | -$18.18 | -$46.74 | -$83.08 | $217.03 |
News
Fundamentals
| Market cap | $275.23M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 39.49M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 1.37 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.50 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 7.70 |
| Quick ratio | 6.77 |